LegalizeVyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů
| 464.1 | R05CB01 | acetylcystein | inhal. | 1.6 | GM | 12,07 | |
|---|---|---|---|---|---|---|---|
| 464.2 | R05CB02 | bromhexin | inhal. | 24 | MG | 3,47 | |
| 464.3 | R05CB05 | mesna | inhal. | 600 | MG | 40,67 | |
| 03614 | MISTABRON | sol 6x3ml/600mg | UCB | B | |||
| 464.4 | R05CB13 | alfadornáza | inhal. | 2.5 | MG | 1197,58 | P |
| 77521 | PULMOZYME 2500UT(2.5MG) | inh sol 6x2.5ml | HLR | CH | |||
| 464.5 | R05CB15 | erdostein | inhal. | 450 | MG | 8,31 | |
| 465 | R05CB | mukolytika | parent. | ||||
| 465.1 | R05CB01 | acetylcystein | parent. | 0.5 | GM | 6,84 | |
| 02206 | BRONCHOLYSIN | inj 5x5ml/1gm | LEX | CZ | |||
| 465.2 | R05CB02 | bromhexin | parent. | 24 | MG | 40,37 | |
| 465.3 | R05CB06 | ambroxol | parent. | 0.15 | GM | 226,02 | |
| 465.4 | R05CA03 | guaifenesin | parent. | 0.9 | GM | 16,57 | |
| 92347 | GUAJACURAN 5% | inj 6x20ml/1gm | LEX | CZ | |||
| 465.5 | R05CB06 | ambroxol (koncentrat k infuzi) | parent. | 1 | DF | 343,81 | H |
| 12839 | MUCOSOLVAN | inf 1x50ml/1000mg | BOE | D | |||
| 466 | R05DA | antitusika ze skupiny derivátů opioidů | p.o. | ||||
| 466.1 | R05DA01 | ethylmorfin do 15 MG včetně | p.o. | 50 | MG | 5,33 | |
| 44590 | DIOLAN 15MG | tbl 10x15mg(blistr) | SLO | SK | |||
| 466.2 | R05DA01 | ethylmorfin nad 15 MG | p.o. | 50 | MG | 4,74 | |
| 44589 | DIOLAN 30MG | tbl 10x30mg(blistr) | SLO | SK | |||
| 466.3 | R05DA04 | kodein | p.o. | 0.1 | GM | 11,27 | |
| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | SLO | SK | |||
| 466.4 | R05DA08 | folkodin | p.o. | 50 | MG | 3,67 | |
| 466.5 | R05DA09 | dextro-methorphan | p.o. | 90 | MG | 3,67 | |
| 466.6 | R05DA20 | kombinace antitusik | p.o. | 3 | DF | 3,67 | |
| 467 | R05DB | antitusika chemicky blízká lokálním anestetikům | p.o., p.rect., parent. | ||||
| 467.1 | R05DB | dropropizin | p.o. | 25 | MG | 2,44 | |
| 04212 | DITUSTAT | gtt 1x10ml | GNO | CZ | |||
| 467.2 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25 | MG | 5,82 | |
| 467.3 | R05DB13 | butamirát (tekuté lékové formy) | p.o. | 25 | MG | 10,56 | |
| 94859 | TUSSIN | gtt 1x10ml | GNO | CZ | |||
| 75936 | SINECOD | sir 1x200ml | ZYM | CH | |||
| 467.4 | R05DB03 | klobutinol | parent. | 120 | MG | 112,03 | H |
| 467.5 | R05DB05 | pentoxyverin (do 8 mg v jednom čípku včetně) | p.rect. | 100 | MG | 139,11 | L/PDD |
| 92252 | SEDOTUSSIN 8MG BABIES | sup 6x8mg | UCB | B | |||
| 467.6 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100 | MG | 63,40 | L/PDD |
| 92253 | SEDOTUSSIN 20MG CHILDREN | sup 6x20mg | UCB | B | |||
| 468 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | p.o. | ||||
| 468.1 | R06AA | embramin | p.o. | 50 | MG | 1,32 | |
| 468.2 | R06AA02 | difenhydramin (pevné lékové formy) | p.o. | 0.2 | GM | 8,36 | |
| 468.3 | R06AA04 | klemastin | p.o. | 2 | MG | 7,72 | |
| 02005 | TAVEGYL | tbl 20x1mg | SAN | CH | |||
| 09789 | TAVEGYL | tbl 20x1mg | KRK | SLO | |||
| 468.4 | R06AA07 | difenylpyralin | p.o. | 10 | MG | 7,72 | |
| 468.5 | R06AA02 | difenhydramin (tekuté lékové formy) | p.o. | 0.2 | GM | 8,99 | |
| 469 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | parent. | O | |||
| 469.1 | R06AA04 | klemastin | parent. | 2 | MG | 32,65 | O |
| 02559 | TAVEGYL | inj 5x2ml/2mg | SAN | CH | |||
| 470 | R06AB | antihistaminika ze skupiny derivátů alkylaminů | p.o. | ||||
| 470.1 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4 | MG | 11,10 | |
| 12514 | FENISTIL 24 | cps ret 10x4mg | NCH | CH | |||
| 470.2 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4 | MG | 8,99 | |
| 470.3 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2 | DF | 8,50 | |
| 471 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | p.o. | ||||
| 471.1 | R06AD02 | prometazin (pevné lékové formy) | p.o. | 25 | MG | 4,99 | |
| 00276 | PROTHAZIN | drg 20x25mg | RPG | D | |||
| 471.2 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25 | MG | 8,99 | |
| 471.3 | R06AD03 | thiethylperazin | p.o. | 13 | MG | 4,25 | |
| 09844 | TORECAN | drg 50x6.5mg | KRK | SLO | |||
| 471.4 | R06AD03 | thiethylperazin | p.rect. | 13 | MG | 21,65 | |
| 09847 | TORECAN | sup 6x6.5mg | KRK | SLO | |||
| 472 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | parent. | O | |||
| 472.1 | R06AD02 | prometazin | parent. | 25 | MG | 7,48 | O |
| 87916 | PHENERGAN | inj 5x2ml/50mg | SPC | F | |||
| 472.2 | R06AD03 | thiethylperazin | parent. | 13 | MG | 26,00 | O |
| 91836 | TORECAN | inj 5x1ml/6.5mg | KRK | SLO | |||
| 473 | R06AX | jiná antihistaminika k systémovému použití | p.o. | ||||
| 473.1 | R06AE06 | oxatomid | p.o. | 60 | MG | 7,04 | |
| 473.2 | R06AE07 | cetirizin (pevné lékové formy) | p.o. | 10 | MG | 8,36 | |
| 473.3 | R06AE07 | cetirizin (tekuté lékové formy) | p.o. | 10 | MG | 8,99 | |
| 473.4 | R06AK | kombinace antihistaminik | p.o. | 2 | DF | 1,08 | |
| 473.5 | R06AX | bisulepin | p.o. | 4 | MG | 3,27 | |
| 02479 | DITHIADEN | tbl 20x2mg | LEX | CZ | |||
| 473.6 | R06AX01 | bamipin | p.o. | 0.1 | GM | 6,06 | |
| 473.7 | R06AX02 | cyproheptadin (pevné lékové formy) | p.o. | 12 | MG | 6,06 | |
| 473.8 | R06AX02 | cyproheptadin (tekuté lékové formy) | p.o. | 12 | MG | 8,99 | |
| 473.9 | R06AX09 | azatadin | p.o. | 2 | MG | 6,06 | |
| 473.10 | R06AX11 | astemizol (pevné lékové formy) | p.o. | 10 | MG | 7,38 | |
| 91839 | HISMANAL | tbl 30x10mg | JAN | B | |||
| 473.11 | R06AX11 | astemizol (tekuté lékové formy) | p.o. | 10 | MG | 8,99 | |
| 473.12 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 7,38 | |
| 87117 | TERFENADIN 60 STADA | tbl 20x60mg | STD | D | |||
| 87118 | TERFENADIN 60 STADA | tbl 50x60mg | STD | D | |||
| 84130 | LOTANAX 60 | tbl 20x60mg | LEX | CZ | |||
| 473.13 | R06AX13 | loratadin (pevné lékové formy) | p.o. | 10 | MG | 8,36 | |
| 53639 | FLONIDAN | tbl 30x10mg | LEK | SLO | |||
| 88734 | FLONIDAN | tbl 10x10mg | LEK | SLO | |||
| 473.14 | R06AX13 | loratadin (tekuté lékové formy) | p.o. | 10 | MG | 8,99 | |
| 01700 | FLONIDAN | sus 1x120ml | LEK | SLO | |||
| 473.15 | R06AX17 | ketotifen (pevné lékové formy) | p.o. | 2 | MG | 7,38 | |
| 84030 | KETOTIFEN TROM | cps 100x1mg | TRM | D | |||
| 473.16 | R06AX17 | ketotifen (tekuté lékové formy) | p.o. | 2 | MG | 8,99 | |
| 473.17 | R06AX18 | akrivastin | p.o. | 24 | MG | 7,38 | |
| 473.18 | R06AX25 | mizolastin | p.o. | 10 | MG | 8,36 | |
| 474 | R06AX | jiná antihistaminika k systémovému použití | parent. | O | |||
| 474.1 | R06AX | bisulepin | parent. | 4 | MG | 25,12 | O |
| 04071 | DITHIADEN | inj 10x2ml/1mg | LEX | CZ | |||
| 474.2 | R06AX | medosulepin/vápník | parent. | 2 | DF | 30,79 | O |
| 00508 | METHIADEN CALCIUM | inj 5x10ml | LEX | CZ | |||
| 475 | R07AA | plicní surfaktanty | parent. | T | |||
| 475.1 | R07AA01 | kolfosceril palmitát | parent. | 108 | MG | 13332,33 | T |
| 475.2 | R07AA02 | přirozené fosfolipidy (telecího původu) | parent. | 1 | DF | 13332,33 | T |
| 475.3 | R07AA02 | přirozené fosfolipidy (vepřového původu) | parent. | 160 | MG | 20087,47 | T |
| 87226 | CUROSURF | sus 2x1.5ml/120mg | CHS | I | |||
| 476 | S01AA | antibiotika k lokálnímu podání | lok. | ||||
| 476.1 | S01AA | neomycin/ polymyxin/ fenylefrin | lok. | 1 | ML | 19,55 | L/OPH |
| 476.2 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1 | ML | 2,79 | |
| 476.3 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1 | GM | 4,45 | |
| 03016 | OPHTHALMO-CHLORAMPHENICOL LECIV | ung oph 1x5gm 1% | LEX | CZ | |||
| 476.4 | S01AA11 | gentamicin | lok. | 1 | ML | 3,03 | |
| 476.5 | S01AA12 | tobramycin (lékové formy očních kapek) | lok. | 1 | ML | 3,03 | |
| 476.6 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1 | GM | 3,03 | |
| 476.7 | S01AA20 | neomycin/ bacitracin/ hydrokortison | lok. | 1 | GM | 5,38 | |
| 01077 | OPHTHALMO-FRAMYKOIN COMPOSITUM | ung oph 1x5gm | LEX | CZ | |||
| 476.8 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1 | ML | 3,03 | |
| 476.9 | S01AA24 | kanamycin | lok. | 1 | ML | 3,03 | |
| 476.10 | S01AA25 | azidamfenikol | lok. | 1 | ML | 3,03 | |
| 90770 | OPHTHALMO-AZAPHENICOL | gtt oph 1x10ml | GNO | CZ | |||
| 476.11 | S01AA30 | neomycin/ bacitracin | lok. | 1 | GM | 4,89 | |
| 01076 | OPHTHALMO-FRAMYKOIN | ung oph 1x5gm | LEX | CZ | |||
| 476.12 | S01AA30 | neomycin/ polymyxin | lok. | 1 | ML | 19,55 | |
| 477 | S01AB | chemoteraputika k lokálnímu podání | lok. | ||||
| 477.1 | S01AB | sulfathiazol | lok. | 1 | GM | 3,42 | |
| 477.2 | S01AB04 | sulfacetamid | lok. | 1 | ML | 7,23 | |
| 93577 | SULPHACETAMID | gtt oph 12x0.5ml | POL | PL | |||
| 478 | S01AD | antivirotika k lokálnímu podání | lok. | L/OPH | |||
| 478.1 | S01AD02 | trifluorothimidin (lékové formy očních mastí) | lok. | 1 | GM | 79,92 | L/OPH |
| 478.2 | S01AD02 | trifluorothimidin (lékové formy očních kapek) | lok. | 1 | ML | 53,23 | L/OPH |
| 65513 | TRIHERPINE | gtt oph 1x5ml | CBV | CH | |||
| 478.3 | S01AD03 | acyklovir | lok. | 1 | GM | 79,92 | L/OPH |
| 93990 | VIROLEX | ung oph 1x4.5gm 3% | KRK | SLO | |||
| 479 | S01AX | ostatní antiinfektiva | lok. | L/OPH | |||
| 479.1 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 2,40 | |
| 00802 | OPHTHALMO-SEPTONEX | gtt oph 1x10ml | GNO | CZ | |||
| 479.2 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 4,30 | |
| 00876 | OPHTHALMO-SEPTONEX | ung oph 1x5gm | LEX | CZ | |||
| 479.3 | S01AX13 | ciprofloxacin | lok. | 1 | ML | 34,22 | L/OPH, ORL |
| 479.4 | S01AX | lomefloxacin | lok. | 1 | ML | 34,22 | L/OPH |
| 480 | S01BA | kortikosteroidy k lokálnímu podání | lok. | ||||
| 480.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3,47 | |
| 93718 | DEXAMETHASONE POLFA | sus oph 10ml 0.1% | POL | PL | |||
| 480.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1 | GM | 3,62 | |
| 480.3 | S01BA02 | hydrokortison | lok. | 1 | GM | 4,84 | |
| 02668 | OPHTHALMO-HYDROCORTISON LECIVA | ung oph 1x5gm 0.5% | LEX | CZ | |||
| 480.4 | S01BA03 | kortison | lok. | 1 | ML | 19,55 | L/OPH |
| 00757 | CORTISON SPOFA | gtt oph 1x3ml | SPX | CZ | |||
| 480.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1 | ML | 19,55 | L/OPH |
| 12487 | PREDNI-POS | gtt oph 1x5ml/25mg | URS | D | |||
| 480.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1 | GM | 19,55 | L/OPH |
| 480.7 | S01BA07 | fluorometholon | lok. | 1 | ML | 19,55 | L/OPH |
| 481 | S01BC | nesteroidní protizánětlivá léčiva k lokálnímu podání | lok. | ||||
| 481.1 | S01BC | alkylazuleny | lok. | 1 | GM | 3,81 | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm | LEX | CZ | |||
| 481.2 | S01BC02 | oxyfenbutazon | lok. | 1 | GM | 14,66 | |
| 481.3 | S01BC03 | diklofenak | lok. | 1 | ML | 36,17 | L/OPH |
| 481.4 | S01BC04 | flurbiprofen | lok. | 1 | ML | 36,17 | L/OPH |
| 482 | S01CA | kortikosteroidy a antiinfektiva k lokálnímu podání | lok. | L/OPH | |||
| 482.1 | S01CA | chloramfenikol/dexamethason | lok. | 1 | ML | 17,60 | L/OPH |
| 482.2 | S01CA | gentamicin/betamethason (lékové formy očních kapek) | lok. | 1 | ML | 13,39 | L/OPH,ORL |
| 91712 | GARASONE | gtt oph 1x5ml | SCH | B | |||
| 482.3 | S01CA | gentamicin/betamethason (lékové formy očních mastí) | lok. | 1 | GM | 17,06 | L/OPH,ORL |
| 91711 | GARASONE | ung oph 1x5gm | SCH | B | |||
| 482.4 | S01CA01 | dexamet./ neomycin/ polymyxin (lékové formy očních kapek) | lok. | 1 | ML | 17,60 | L/OPH |
| 482.5 | S01CA01 | dexamet./ neomycin/ polymyxin (lékové formy očních mastí) | lok. | 1 | GM | 17,60 | L/OPH |
| 482.6 | S01CA01 | oxytetracyklin/dexamethason | lok. | 1 | GM | 17,60 | L/OPH |
| 482.7 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 17,60 | L/OPH |
| 482.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 17,60 | L/OPH |
| 482.9 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 19,55 | L/OPH |
| 482.10 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 24,44 | L/OPH |
| 482.11 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních mastí) | lok. | 1 | GM | 17,60 | L/OPH |
| 482.12 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních kapek) | lok. | 1 | ML | 17,60 | L/OPH |
| 483 | S01EA | lokální sympatomimetika k léčbě glaukómu | lok. | L/OPH | |||
| 483.1 | S01EA01 | epinefrin | lok. | 0.2 | ML | 5,57 | L/OPH |
| 483.2 | S01EA02 | dipivefrin | lok. | 0.2 | ML | 5,57 | L/OPH |
| 54270 | OFTANEX | gtt oph 1x10 ml | SOY | SF | |||
| 483.3 | S01EA04 | klonidin | lok. | 1 | ML | 11,29 | L/OPH |
| 49501 | ARUCLONIN 1/16% | gtt oph 10 ml | ANW | D | |||
| 20766 | AUCLONIN 1/8% | gtt oph 10 ml | ANW | D | |||
| 484 | S01EB | lokální parasympatomimetika k léčbě glaukómu | lok. | L/OPH | |||
| 484.1 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1 | GM | 32,26 | |
| 484.2 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1 | ML | 10,75 | |
| 03865 | PILOCARPIN ANKERPHARM 2% | gtt ole oph 1x10ml | ANW | D | |||
| 484.3 | S01EB01 | pilokarpin (lékové formy očních kapek) | lok. | 1 | ML | 7,63 | |
| 04146 | PILOCARPIN ANKERPHARM 2% | gtt oph 1x10ml | ANW | D | |||
| 57337 | PILOCARPIN ANKERP.OCNI KAPKY 2% | gtt oph 3x10ml | CHV | D | |||
| 484.4 | S01EB02 | karbachol (koncentrace do 1 % včetně) | lok. | 1 | ML | 8,50 | L/OPH |
| 20932 | JESTRYL VISKOS | gtt oph 1x10ml 1% | ANW | D | |||
| 484.5 | S01EB02 | karbachol (koncentrace nad 1% do 1,5% včetně) | lok. | 1 | ML | 6,06 | L/OPH |
| 484.6 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1 | ML | 6,60 | L/OPH |
| 484.7 | S01EB06 | neostigmin | lok. | 1 | ML | 13,88 | L/OPH |
| 484.8 | S01EB51 | pilokarpin v kombinaci s timololem | lok. | 1 | ML | 31,28 | L/OPH |
| 485 | S01EC | inhibitory karboanhydrázy k celkovému podání | p.o. | ||||
| 485.1 | S01EC01 | acetazolamid | p.o. | 0.75 | GM | 5,38 | |
| 00113 | DILURAN | tbl 20x250mg | LEX | CZ | |||
| 485.2 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | GM | 29,33 | |
| 485.3 | S01EC02 | diklofenamid | p.o. | 0.1 | GM | 6,26 | |
| 485.4 | S01EC03 | dorzolamid | lok. | 1 | ML | 66,48 | L/OPH |
| 486 | S01ED | lokální beta-blokátory k léčbě glaukómu | lok. | ||||
| 486.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1 | ML | 16,13 | |
| 76186 | ARUTIMOL 0.25% | gtt oph 1x5ml | ANW | D | |||
| 70474 | ARUTIMOL 0.25% | gtt oph 3x5ml | ANW | D | |||
| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D | |||
| 98210 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.25% | LEX | CZ | |||
| 93294 | OCUPRES-E | gtt oph 5ml 0.25% | CAD | IND | |||
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | POL | PL | |||
| 12732 | TIMOHEXAL 0.1% | gtt oph 3x5ml/5mg | HEX | D | |||
| 12729 | TIMOHEXAL 0.1% | gtt oph 1x5ml/5mg | HEX | D | |||
| 12733 | TIMOHEXAL 0.25% | gtt oph3x5ml/12.5mg | HEX | D | |||
| 12730 | TIMOHEXAL 0.25% | gtt oph1x5ml/12.5mg | HEX | D | |||
| 11664 | OFTAN TIMOLOL | gtt oph 1x5ml 0.25% | LOY | SF | |||
| 486.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1 | ML | 18,57 | |
| 93293 | OCUPRES-E | gtt oph 5ml 0.50% | CAD | IND | |||
| 96020 | OFTENSIN 0.5% | gtt oph 1x10ml | POL | PL | |||
| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | D | |||
| 76187 | ARUTIMOL 0.5% | gtt oph 1x5ml | ANW | D | |||
| 70475 | ARUTIMOL 0.5% | gtt oph 3x5ml | ANW | D | |||
| 98211 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.50% | LEX | CZ | |||
| 12734 | TIMOHEXAL 0.5% | gtt oph 3x5ml/25mg | HEX | D | |||
| 12731 | TIMOHEXAL 0.5% | gtt oph 1x5ml/25mg | HEX | D | |||
| 11665 | OFTAN TIMOLOL | gtt oph 1x5ml 0.50% | LOY | SF | |||
| 486.3 | S01ED02 | betaxolol | lok. | 1 | ML | 28,15 | L/OPH |
| 486.4 | S01ED03 | levobunolol | lok. | 1 | ML | 28,15 | L/OPH |
| 486.5 | S01ED04 | metipranolol | lok. | 1 | ML | 13,20 | |
| 486.6 | S01ED05 | carteolol | lok. | 1 | ML | 28,15 | L/OPH |
| 486.7 | S01EX03 | latanoprost | lok. | 1 | ML | 234,62 | P |
Terapii xalatanem ordinuje oční lékař, není-li po vyčerpání všech možností antiglautomatosní terapie pacient kompenzován.
| 487 | S01F | mydriatika a cykloplegika | lok. | O/OPH | |||
|---|---|---|---|---|---|---|---|
| 487.1 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,10 | O/OPH |
| 487.2 | S01FA06 | tropikamid | lok. | 1 | ML | 8,99 | O/OPH |
| 21155 | MYDRUM | gtt oph 10ml 0.5% | ANW | D | |||
| 487.3 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 40,33 | O/OPH |
| 487.4 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,18 | |
| 83770 | ATROPIN-POS 0.5% | gtt oph 1x10ml | URS | D | |||
| 487.5 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 5,87 | |
| 83771 | ATROPIN-POS 1% | gtt oph 1x10ml | URS | D | |||
| 488 | S01G | dekongestanty a antialergika | lok. | L/OPH,ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 488.1 | S01GA52 | tetryzolin/ antihistaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG |
| 21521 | PROTHANON | gtt oph 10ml | GMD | D | |||
| 488.2 | S01GX | antazolin/ tetryzolin | lok. | 1 | ML | 6,06 | L/OPH,ALG |
| 488.3 | S01GX01 | kyselina kromoglyková (lékové formy očních kapek) | lok. | 1 | ML | 6,06 | L/OPH,ALG |
| 83769 | ALLERGOCROM | gtt oph 1x10ml 2% | URS | D | |||
| 68575 | CROMOHEXAL | gtt oph 1x10ml 2% | HEX | D | |||
| 488.4 | S01GX01 | kyselina kromoglyková (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,43 | L/OPH,ALG,ORL |
| 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | |||
| 488.5 | S01GX02 | levokabastin | lok. | 1 | ML | 17,60 | L/OPH,ALG |
| 488.6 | S01GX05 | lodoxamid | lok. | 1 | ML | 14,66 | L/OPH,ALG |
| 488.7 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 14,66 | L/OPH,ALG |
| 489 | S01HA | lokální místní anestetika | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 11,83 | L/OPH |
| 489.2 | S01HA02 | oxybuprokain | lok. | 1 | ML | 11,83 | L/OPH |
| 66524 | NOVESIN 0.4% | gtt oph 1x10ml | CBV | CH | |||
| 490 | S01 | jiná oftalmologika | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 490.1 | S01XA | tolazolin (koncentrace 10%) | lok. | 1 | GM | 14,91 | L/OPH |
| 490.2 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 2,93 | |
| 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | |||
| 490.3 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1376,58 | Z |
| 31339 | IAL | inj 1x2ml/20mg | FID | I | |||
| 490.4 | S01XA02 | retinol | lok. | 1 | GM | 2,93 | |
| 490.5 | S01XA | jodid draselný | lok. | 1 | ML | 4,89 | |
| 56118 | JODID DRASELNY 2% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | |||
| 490.6 | S01XA | jodid draselný a sodný | lok. | 1 | ML | 4,89 | |
| 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | gtt oph 1x10ml | UPA | SK | |||
| 490.7 | S01XA | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1 | GM | 2,93 | |
| 491 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | L/ORL | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 491.1 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | ML | 27,37 | L/ORL |
| 491.2 | S02AA11 | polymyxin B | lok. | 1 | ML | 2,64 | L/ORL |
| 02830 | POLYMYXIN B | gtt oto 10ml 100ku | GNO | CZ | |||
| 491.3 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | GM | 22,92 | L/ORL, PDD |
| 84575 | OTOBACID N | gtt oto 1x6gm | ASH | D | |||
| 492 | V01AA | extrakty alergenů | p.o. | L/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 492.1 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, plná terapeutická dávka) | p.o. | 1 | BA | 898,40 | L/ALG |
| 98400 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98409 | H-AL BACT.SEVAC P.O.SMES DCD | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98460 | H-AL MYCO SEVAC P.O.SM.PL.DOMOV | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98403 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 492.2 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, nejvyšší koncentrace) | p.o. | 1 | BA | 432,68 | L/ALG |
| 492.3 | V01AA | extrakty alergenů (nestandardizované, z hmyzu, z roztočů, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 90% | L/ALG |
| 492.4 | V01AA | extrakty alergenů (nestandardizované, z hmyzu, z roztočů, nejvyšší koncentrace) | p.o. | 1 | BA | 90% | L/ALG |
| 492.5 | V01AA | extrakty alergenů (nestandardizované, z plísní, individuální alergeny) | p.o. | 1 | BA | 90% | L/ALG |
| 492.6 | V01AA | extrakty alergenů (nestandardizované, z prachu obohacené, individuální alergeny) | p.o. | 1 | BA | 90% | L/ALG |
| 492.7 | V01AA | extrakty alergenů (nestandardizované, z prachu, včetně obohacených, nejvyšší koncentrace) | p.o. | 1 | BA | 90% | L/ALG |
| 492.8 | V01AA | extrakty alergenů (nestadnardizované, z prachu, včetně obohacených, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 90% | L/ALG |
| 492.9 | V01AA | extrakty alergenů (nestandardizované, z pylů, plná terapeutická dávka pro pacienta a individuální alergeny) | p.o. | 1 | BA | 90% | L/ALG |
| 492.10 | V01AA | extrakty alergenů (nestandardizované, z pylů, nejvyšší koncentrace) | p.o. | 1 | BA | 90% | L/ALG |
| 492.11 | V01AA | extrakty alergenů (standardizované, úvodní dávka) | p.o. | 1 | DF | 355,64 | L/ALG |
| 492.12 | V01AA | extrakty alergenů (standardizované, udržovací dávka dávka) | p.o. | 1 | DF | 692,22 | L/ALG |
| 493 | V01AA | extrakty alergenů | intrader. | O/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 134,61 | O/ALG |
| 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98514 | D-AL MITES SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98516 | D-AL MITES SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98523 | D-AL INSECTS SEVAC | inj 5ml od 0.5pnu | USO | CZ | |||
| 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | |||
| 494 | V01AA | extrakty alergenů | PRICK test | O/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 494.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG |
| 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | |||
| 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | |||
| 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | |||
| 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG |
| 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | |||
| 494.3 | V01AA | extrakty alergenů (diagnostické, souprava) | PRICK test | 1 | BA | 527,40 | O/ALG |
| 494.4 | V01AA | extrakty alergenů (diagnostické, souprava), jinde nezařazené | PRICK test | 1 | BA | 50 % | O/ALG |
| 495 | V01AA | extrakty alergenů | parent. | L/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 495.1 | V01AA | extrakty alergenů (nestandardizované, bakteriální, indiviuální dle rozpisu lékaře) | parent. | 1 | BA | 90% | L/ALG |
| 495.2 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 90% | L/ALG |
| 495.3 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, nejvyšší koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.4 | V01AA | extrakty alergenů (nestandardizované, obecné individuální alergeny dle rozpisu lékaře) | parent. | 1 | BA | 90% | L/ALG |
| 495.5 | V01AA | extrakty alergenů (nestandardizované, z roztočů, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 90% | L/ALG |
| 495.6 | V01AA | extrakty alergenů (nestandardizované, z roztočů, nejvyšší koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.7 | V01AA | extrakty alergenů (nestandardizované, z hmyzu, z roztočů depotní, ostatní koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.8 | V01AA | extrakty alergenů (nestandardizované, z hmyzu, z roztočů depotní, nejvyšší koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.9 | V01AA | extrakty alergenů (nestandardizované, z plísní dle rozpisu lékaře, individuální alergeny) | parent. | 1 | BA | 90% | L/ALG |
| 495.10 | V01AA | extrakty alergenů (nestandardizované, z prachu, včetně obohacených, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 90% | L/ALG |
| 495.11 | V01AA | extrakty alergenů (nestandardizované, z prachu, včetně obohacených, nejvyšší koncetrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.12 | V01AA | extrakty alergenů (nestandardizované, z prachu, včetně obohacených depotní, ostatní koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.13 | V01AA | extrakty alergenů (nestandardizované, z prachu, včetně obohacených depotní, nejvyšší koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.14 | V01AA | extrakty alergenů (nestandardizované, z pylů individuální alergeny dle rozpisu lékaře) | parent. | 1 | BA | 90% | L/ALG |
| 495.15 | V01AA | extrakty alergenů (nestandardizované, z pylů, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 90% | L/ALG |
| 495.16 | V01AA | extrakty alergenů (nestandardizované, z pylů, udržovací dávka) | parent. | 1 | BA | 90% | L/ALG |
| 495.17 | V01AA | extrakty alergenů (nestandardizované, z pylů, nejvyšší koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.18 | V01AA | extrakty alergenů (nestandardizované, z pylů depotní, ostatní koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.19 | V01AA | extrakty alergenů (nestandardizované, z pylů depotní, nejvyšší koncentrace) | parent. | 1 | BA | 90% | L/ALG |
| 495.20 | V01AA extrakty alergenů (standardizované, úvodní dávka) | parent. | 1 | DF | 355,64 | L/ALG | |
| 495.21 | V01AA extrakty alergenů (standardizované, udržovací dávka) | parent. | 1 | DF | 1168,01 | L/ALG | |
| 93786 | POLLINEX | inj 3x0.5ml/2ku | SKB | GB | |||
| 69201 | ALUTARD SQ (TERAP.) 10KU/ML | inj 1x4ml (lahv.3) | EAS | A | |||
| 495.22 | V01AA | extrakty alergenů ( z hmyzu, plná terapeutická dávka pro pacienta) | parent. | 1 | DF | 239,02 | L/ALG |
| 99709 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 6x10ml | USO | CZ | |||
| 99710 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 7x10ml | USO | CZ | |||
| 99723 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 1x5000pnu 1:1 | USO | CZ | |||
| 99721 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 6x10ml 1:1 | USO | CZ | |||
| 99712 | H-AL INS.SEVAC INJ.VOSI EXTR. | inj 6x10ml | USO | CZ | |||
| 99716 | H-AL INS.SEVAC KOMARI | inj 7x10ml | USO | CZ | |||
| 99722 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 7x10ml 1:1 | USO | CZ | |||
| 495.23 | V01AA | extrakty alergenů (z hmyzu, nejvyšší koncentrace) | parent. | 1 | DF | 747,16 | L/ALG |
| 99711 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 1x5000pnu | USO | CZ | |||
| 99723 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 1x5000pnu 1:1 | USO | CZ | |||
| 495.24 | V01AA | extrakty alergenů (standardizované, z hmyzu, úvodní dávka) | parent. | 1 | DF | 355,64 | Z |
| 495.25 | V01AA | extrakty alergenů (standardizované, z hmyzu, udržovací dávka) | parent. | 1 | DF | 1168,01 | Z |
| 57371 | ALUTARD SQ INSECT. 10KU/ML | inj 1x4ml (lahv.3) | EAS | A | |||
| 496 | V03A | všechny jiné terapeutické přípravky | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 496.1 | V03A | antistafylokokový fág. lyzát | lok. | 20 | ML | 289,60 | |
| 86170 | STAFAL SEVAC | sus 1x10ml | SEV | CZ | |||
| 497 | V03AB | antidota | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 497.1 | V03AB | deferoxamin | parent. | 1 | GM | 393,57 | K |
| 01445 | DESFERAL | inj sic 10x500mg | CGC | CH | |||
| 497.2 | V03AB | trimedoxim + atropin | parent. | plně | K | ||
| 497.3 | V03AB | obedoxim | parent. | plně | K | ||
| 497.4 | V03AB03 | edetáty | parent. | plně | K | ||
| 497.5 | V03AB06 | thiosulfát | parent. | plně | K | ||
| 497.6 | V03AB08 | dusitan sodný | parent. | plně | K | ||
| 497.7 | V03AB14 | protamin | parent. | 1 | ML | 6,01 | K |
| 85787 | PROTAMIN SULFAT 1% GALENIKA | inj 5x5ml/50mg 1% | GLN | YU | |||
| 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 11,83 | K |
| 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | |||
| 94763 | NALOXONE POLFA | inj 10x1ml/0.4mg | POL | PL | |||
| 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 20,43 | K |
| 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,31 | K |
| 00557 | PHYSOSTIGMIN SPOFA | inj 10x1ml/1mg | SPX | CZ | |||
| 497.11 | V03AB24 | digitalisový antitoxin | parent. | 80 | MG | 32726,64 | K |
| 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 777,86 | K |
| 93214 | ANEXATE | inj 5x5ml/0.5mg | HLR | CH | |||
| 498 | V03AF | antidota užívaná při léčbě cytostatiky | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 498.1 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 113,99 | |
| 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | |||
| 498.2 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 117,55 | |
| 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | |||
| 498.3 | V03AF01 | mesna | p.o. | 1,2 | GM | 297,04 | B/ONK,HEM |
| 87251 | UROMITEXAN TABLETS 400MG | tbl obd 10x400mg | ASD | D | |||
| 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 29,72 | B/ONK,HEM |
| 72562 | UROMITEXAN 200MG | inj 15x2ml/200mg | ASD | D | |||
| 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 49,42 | B/ONK,HEM |
| 75274 | UROMITEXAN 400MG | inj 15x4ml/400mg | ASD | D | |||
| 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4391,10 | B/ONK,HEM |
| 96542 | CARDIOXANE | inj sic 1x500mg | CNC | NL | |||
| 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 234,23 | B/ONK,HEM |
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj sic 10x10mg | LCM | CZ | |||
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | |||
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj sic 1x25mg | LCM | CZ | |||
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj sic 10x25mg | LCM | CZ | |||
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj 5x5ml/50mg | LCM | CZ | |||
| 500 | V03AK | tkáňová lepidla | lok. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3227,24 | X |
| 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | |||
| 90503 | TISSUCOL KIT | kit 1x1ml | IMM | A | |||
| 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | |||
| 90505 | TISSUCOL KIT | kit 1x5ml | IMM | A | |||
| 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 177,53 | X |
| 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | |||
| 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | |||
| 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | K/END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 421,88 | K/END |
| 01359 | METOPIRONE | cps 50x250mg | CGC | CH | |||
| 502 | V04CF | tuberkulinový test | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 502.1 | V04CF01 | tuberkulin | parent. | 0.6 | RG | 277,44 | H |
| 68918 | TUBERCULIN PPD RT 23,SSI | inj 10x1.5ml/0.6rg | SST | DK | |||
| 68920 | TUBERCULIN PPD RT 23,SSI | inj 10x5ml/2rg | SST | DK | |||
| 68919 | TUBERCULIN PPD RT 23,SSI | inj 1x5ml/2rg | SST | DK | |||
| 503 | V04CL | testy pro alergické choroby | intrader. | O/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 503.1 | V04CL | testy pro alergické choroby (diagnostické alergeny) | intrader. | 1 | BA | 210,80 | O/ALG |
| 84296 | D-AL SEVAC PRICK TEST | sol 1x3ml/3000pnu | SEV | CZ | |||
| 503.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1 | BA | 495,05 | O/ALG |
| 69220 | ALK WASSERIG SQ(DIAG.)100KU/ML | lyo 1x4.5ml+solv. | EAS | A | |||
| 84294 | D-AL POLLENS SEVAC PRICK TEST I | kit 17x3ml/3000pnu | SEV | CZ | |||
| 504 | V04CX | jiná diagnostika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 22,88 | |
| 06300 | CO2 GRANULAT GUERBET | gra 10x2.938gm | GUE | D | |||
| 505 | V04CX | jiná diagnostika | intrader. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 127,09 | O |
| 94513 | IMUNOSKINTEST SEVAC I.D. | inj 8x1ml | SEV | CZ | |||
| 45918 | IMUNOSKINTEST | inj 2x1.5+6x1.3ml | SVF | CZ | |||
| 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 251,00 | O |
| 90636 | PATENTBLAU V | inj 1x2ml/50mg | BGL | D | |||
| 506 | V04CX | jiná diagnostika | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 506.1 | V04CG03 | histamin | parent. | 10 | MG | 10,07 | O |
| 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5,47 | O |
| 00416 | COFFEINUM NATRIUM BENZ. LECIVA | inj 10x1ml 10% | LEX | CZ | |||
| 506.3 | V04CH01 | inulin | parent. | 5 | GM | 489,33 | O |
| 506.4 | V04CJ02 | protirelin | parent. | 0.2 | MG | 215,75 | O |
| 506.5 | V04CK01 | sekretin | parent. | 29 | RG | 919,90 | O |
| 506.6 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.1 | MG | 225,63 | O |
| 506.7 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.1 | MG | 680,30 | O |
| 09612 | RELEFACT LH-RH | inj 10x1ml/100rg | HOE | D | |||
| 97829 | RELISORM L 100 | inj sic 1x100rg+sol | LSE | CH | |||
| 506.8 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1 | ML | 34,56 | O |
| 506.9 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1 | ML | 126,50 | O |
| 90567 | FLUORESCITE | inj 12x2ml 25% | ALC | USA | |||
| 506.10 | V04CE01 | galaktóza | parent. | 1 | DF | 903,92 | O |
| 506.11 | V04CX | urea | p.o. | 1 | DF | 1270,85 | Z |
| 507 | V06CA | výživa bez fenylalaninu | p.o. | L/J4 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 507.1 | V06CA | výživa bez fenylalaninu (suplemen-tovaný bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,33 | L/J4 |
| 94078 | SINFEMIX | plv 1x250gm | IMA | SK | |||
| 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,08 | L/J4 |
| 88063 | SINFENAL | plv 1x250gm | IMA | SK | |||
| 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,81 | L/J4 |
| 93088 | MILUPA PKU 2 | plv po 1x500gm | MLP | D | |||
| 93087 | MILUPA PKU 1 | plv po 1x500gm | MLP | D | |||
| 93089 | MILUPA PKU 3 | plv po 1x500gm | MLP | D | |||
| 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 25,27 | L/J4 |
| 68847 | ANALOG PKU | plv 6x400gm | SGR | GB | |||
| 94414 | ANALOG PKU | plv 1x400gm | SGR | GB | |||
| 507.5 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1 | GM | 14,17 | L/J4 |
| 508 | V06DA | kombinace sacharidy/proteiny/minerály/vitamíny | p.o. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 508.1 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80 | GM | 87,40 | H |
| 97892 | PRECITENE MCT 50 VANILLE | plv 6x80gm | WAN | D | |||
| 97998 | PRECITENE MCT 50 ORANGE | plv 6x80gm | WAN | D | |||
| 98000 | PRECITENE MCT 50 HIMBEER | plv 6x80gm | WAN | D | |||
| 98002 | PRECITENE MCT 50 OXTAIL | plv 6x80gm | WAN | D | |||
| 508.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 74,25 | H |
| 509 | V06DB | kombinace tuk/sacharidy/proteiny/minerály/vitamíny | p.o. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, omb. | p.o. | 100 | GM | 44,87 | H |
| 61454 | NUTRISON | plv 1x430gm | NUT | NL | |||
| 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 79,38 | H |
| 509.3 | V06DC | kombinace sacharidů | p.o. | 100 | GM | 44,87 | H |
| 510 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | L/J7 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 90,33 | L/J7 |
| 88115 | KETOSTERIL | tbl obd 100 | FRE | D | |||
| 88116 | KETOSTERIL | tbl obd 300 (3x100) | FRE | D | |||
| 88117 | KETOSTERIL | tbl obd 1500=15x100 | FRE | D | |||
| 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | L/J11 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 511.1 | V06DE | kombinace aminokyseliny/sacharidy/minerály/ vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100 | GM | 26,88 | |
| 72883 | ENFALAC PRAEMATURE FORMULA | plv 1x400gm | BMS | USA | |||
| 511.2 | V06DE | kombinace aminokyseliny/sacharidy/ minerály/ vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100 | GM | 13,83 | L/J11 |
| 511.3 | V06DE | kombinace aminokyseliny/sacharidy/ minerály/ vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 |
| 511.4 | V06DE | kombinace aminokyseliny/sacharidy/ minerály/ vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100 | GM | 63,54 | L/J11 |
| 512 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | L/J11 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 512.1 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100 | GM | 27,96 | L/J11 |
| 75946 | ISOMIL | plv 1x400gm | ABB | USA | |||
| 513 | V06DX | jiné kombinace přípravků pro výživu | p.o. | L/J11 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 513.1 | V06DX | MCT olej | p.o. | 100 | ML | 103,13 | L/J11 |
| 514 | V07AB | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 514.1 | V07AB | voda pro injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,69 | |
| 00383 | AQUA PRO INJECTIONE BIOTIKA | inj 10x2ml | BTA | SK | |||
| 514.2 | V07AB | voda pro injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10 | ML | 3,32 | |
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml | BTA | SK | |||
| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100x10ml | BTA | SK | |||
| 83700 | WATER FOR INJECTION B.P.CORE | inj 50x10ml | CPL | IND | |||
| 83699 | WATER FOR INJECTION B.P.CORE | inj 50x5ml | CPL | IND | |||
| 514.3 | V07AB | voda pro injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100 | ML | 13,98 | |
| 00657 | AQUA PRO INJECTIONE IMUNA | inf 1x400ml | IMA | SK | |||
| 66642 | AQUA PRO INJECTIONE CIV | sol 1x500ml | CIV | CZ | |||
| 67802 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml | IMA | SK | |||
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | |||
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x500ml | MVM | CZ | |||
| 89245 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x400ml | ARD | CZ | |||
| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | |||
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml (vak) | MKS | CZ | |||
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml (vak) | MKS | CZ | |||
| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | |||
| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml | IHO | CZ | |||
| 97727 | WATER FOR INJECTION BIEFFE | inf 1x500ml(sklo) | BFF | I | |||
| 97726 | WATER FOR INJECTION BIEFFE | inf 1x250ml(sklo) | BFF | I | |||
| 69788 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x300ml | ARD | CZ | |||
| 57775 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFH | E | |||
| 44560 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 12x500ml | SFR | I | |||
| 515 | V08A | rozpustné nefrotropní RTG kontrastní látky | p.o. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 515.1 | V08AA05 | kyselina ioxitalamová | p.o. | 10 | ML | 59,19 | K |
| 93497 | TELEBRIX GASTRO | sol 1x100ml | BGL | D | |||
| 515.2 | V08AB04 | iopamidol | p.o. | 10 | ML | 59,19 | K |
| 516 | V08AA | rozpustné nefrotropní hyperosmolární RTG kontrastní látky | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 516.1 | V08A | meglumin amidotrizoát | parent. | 10 | ML | 73,51 | K |
| 516.2 | V08AA03 | iodamid (koncentrace 300 mg I/ml) | parent. | 10 | ML | 41,06 | K |
| 516.3 | V08AA03 | iodamid (koncentrace 380 mg I/ml) | parent. | 10 | ML | 44,97 | K |
| 516.4 | V08AA03 | iodamid (koncentrace 410 mg I/ml) | parent. | 10 | ML | 87,40 | K |
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg I/ml) | parent. | 10 | ML | 54,74 | K |
| 92348 | TELEBRIX N 300 | inj 6x20ml | LEX | CZ | |||
| 516.6 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg I/ml a více) | parent. | 10 | ML | 63,35 | K |
| 92349 | TELEBRIX N 350 | inj 6x20ml | LEX | CZ | |||
| 92350 | TELEBRIX N 380 | inj 6x20ml | LEX | CZ | |||
| 517 | V08AB | rozpustné nefrotropní nízkoosmolání RTG kontrastní látky | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Vyšetření iotrolanem ordinuje rentgenolog:
- a) pro intrathekální podání,
- b) v ostatních případech po předchozím schválení revizním lékařem.
| 517.1 | V08AB02 | iohexol (koncentrace 180 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 243,27 | K |
|---|---|---|---|---|---|---|---|
| 87801 | OMNIPAQUE 180 | inj 10x10ml | NYI | N | |||
| 87802 | OMNIPAQUE 180 | inj 10x15ml | NYI | N | |||
| 517.2 | V08AB02 | iohexol (koncentrace 240 mg I/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 209,89 | K |
| 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N | |||
| 87602 | OMNIPAQUE 240 | inj 6x20ml | NYI | N | |||
| 517.3 | V08AB02 | iohexol (koncentrace 240 mg I/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 290,63 | K |
| 94219 | OMNIPAQUE 240 | inj 10x10ml | NYI | N | |||
| 517.4 | V08AB02 | iohexol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 161,45 | K |
| 04338 | OMNIPAQUE 240 | inj 10x50ml | NYI | N | |||
| 04339 | OMNIPAQUE 240 | inj 6x200ml | NYI | N | |||
| 517.5 | V08AB02 | iohexol (koncentrace 300 mg I/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 244,00 | K |
| 04328 | OMNIPAQUE 300 | inj 6x20ml | NYI | N | |||
| 04329 | OMNIPAQUE 300 | inj 25x20ml | NYI | N | |||
| 517.6 | V08AB02 | iohexol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 337,85 | K |
| 94220 | OMNIPAQUE 300 | inj 10x10ml | NYI | N | |||
| 517.7 | V08AB02 | iohexol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 04330 | OMNIPAQUE 300 | inj 10x50ml (sklo) | NYI | N | |||
| 62466 | OMNIPAQUE 300 | inj 10x50ml (pp) | NYI | N | |||
| 87600 | OMNIPAQUE 300 | inj 10x100ml | NYI | N | |||
| 517.8 | V08AB02 | iohexol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 272,60 | K |
| 04332 | OMNIPAQUE 350 | inj 6x20ml | NYI | N | |||
| 04333 | OMNIPAQUE 350 | inj 25x20ml | NYI | N | |||
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 209,69 | K |
| 87603 | OMNIPAQUE 350 | inj 10x50ml (sklo) | NYI | N | |||
| 62467 | OMNIPAQUE 350 | inj 10x50ml (pp) | NYI | N | |||
| 04335 | OMNIPAQUE 350 | inj 10x100ml | NYI | N | |||
| 75261 | OMNIPAQUE 350 | inj 6x200ml | NYI | N | |||
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,38 | K |
| 88645 | HEXABRIX 320(HEXABRIX 85) | inj 20ml | BGL | D | |||
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 196,74 | K |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 255,30 | K |
| 71989 | IOPAMIRO 200 | inj 5x10ml | BCC | I | |||
| 88657 | IOPAMIRO 200 | inj 1x10ml | BCC | I | |||
| 517.13 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 315,56 | K |
| 71993 | IOPAMIRO 300 | inj 5x10ml | BCC | I | |||
| 88654 | IOPAMIRO 300 | inj 1x10ml | BCC | I | |||
| 517.14 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 195,71 | K |
| 88655 | IOPAMIRO 300 | inj 1x30ml | BCC | I | |||
| 517.15 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,60 | K |
| 71994 | IOPAMIRO 300 | inj 1x100ml | BCC | I | |||
| 88656 | IOPAMIRO 300 | inj 1x50ml | BCC | I | |||
| 517.16 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 385,26 | K |
| 88658 | IOPAMIRO 370 | inj 1x10ml | BCC | I | |||
| 517.17 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 236,77 | K |
| 88659 | IOPAMIRO 370 | inj 1x30ml | BCC | I | |||
| 517.18 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 190,63 | K |
| 71988 | IOPAMIRO 370 | inj 1x100ml | BCC | I | |||
| 88660 | IOPAMIRO 370 | inj 1x50ml | BCC | I | |||
| 517.19 | V08AB05 | iopromid (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 161,45 | K |
| 77015 | ULTRAVIST-240 | inj 10x50ml | SAG | D | |||
| 517.20 | V08AB05 | iopromid (koncentrace 300 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 244,00 | K |
| 77024 | ULTRAVIST-300 | inj 10x20ml | SAG | D | |||
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 77017 | ULTRAVIST-300 | inj 10x100ml | SAG | D | |||
| 77016 | ULTRAVIST-300 | inj 10x50ml | SAG | D | |||
| 93627 | ULTRAVIST-300 | inj 1x50ml | SAG | D | |||
| 93628 | ULTRAVIST-300 | inj 1x100ml | SAG | D | |||
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 218,29 | K |
| 77019 | ULTRAVIST-370 | inj 10x100ml | SAG | D | |||
| 77018 | ULTRAVIST-370 | inj 10x50ml | SAG | D | |||
| 93625 | ULTRAVIST-370 | inj 1x100ml | SAG | D | |||
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 452,33 | K/P |
| 96349 | ISOVIST 240 | inj 1x10ml 240mg/ml | SAG | D | |||
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 562,40 | K/P |
| 96351 | ISOVIST 300 | inj 1x10ml 300mg/ml | SAG | D | |||
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 125,77 | K |
| 68772 | OPTIRAY 160 | inj 10x50ml | MME | D | |||
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 161,45 | K |
| 68922 | OPTIRAY 240 | inj 10x100ml | MME | D | |||
| 98298 | OPTIRAY 240 | inj 10x50ml | MME | D | |||
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 337,85 | K |
| 92365 | OPTIRAY 300 | inj 10x10ml | MME | D | |||
| 517.28 | V08AB07 | ioversol (koncentrace 300 mg I/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 244,00 | K |
| 68923 | OPTIRAY 300 | inj 10x20ml | MME | D | |||
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 68850 | OPTIRAY 300 | inj 10x50ml | MME | D | |||
| 92366 | OPTIRAY 300 | inj 10x75ml | MME | D | |||
| 92368 | OPTIRAY 300 | inj 10x150ml | MME | D | |||
| 92369 | OPTIRAY 300 | inj 10x200ml | MME | D | |||
| 92367 | OPTIRAY 300 | inj 10x100ml | MME | D | |||
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 196,74 | K |
| 68773 | OPTIRAY 320 | inj 10x50ml | MME | D | |||
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 272,60 | K |
| 92370 | OPTIRAY 350 | inj 10x30ml | MME | D | |||
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 209,69 | K |
| 68925 | OPTIRAY 350 | inj 10x100ml | MME | D | |||
| 92371 | OPTIRAY 350 | inj 10x200ml | MME | D | |||
| 68851 | OPTIRAY 350 | inj 10x50ml | MME | D | |||
| 517.33 | V08AB10 | iomeprol (koncentrace 150 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 122,00 | K |
| 517.34 | V08AB10 | iomeprol (koncentrace 200 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 144,34 | K |
| 517.35 | V08AB10 | iomeprol (koncentrace 250 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,75 | K |
| 517.36 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 244,00 | K |
| 517.37 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 517.38 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 272,60 | K |
| 517.39 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 209,69 | K |
| 517.40 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 300,90 | K |
| 517.41 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 231,44 | K |
| 517.42 | V08AB09 | iodixanol (koncentrace 150mgI/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 226,80 | K |
| 84340 | VISIPAQUE 150MG I/ML | inj 6x200ml | NYI | N | |||
| 84339 | VISIPAQUE 150MG I/ML | inj 10x50ml | NYI | N | |||
| 45114 | VISIPAQUE 150MG I/ML | inj 10x50ml | NRI | IRL | |||
| 45115 | VISIPAQUE 150MG I/ML | inj 6x200ml | NRI | IRL | |||
| 517.43 | V08AB09 | iodixanol (koncentrace 270mgI/ml, do 30 ml včetně v jedné ampuli ) | parent. | 10 | ML | 354,32 | K |
| 84341 | VISIPAQUE 270MG I/ML | inj 10x20ml | NYI | N | |||
| 45118 | VISIPAQUE 270MG I/ML | inj 10x20ml | NRI | IRL | |||
| 517.44 | V08AB09 | iodixanol (koncentrace 270mgI/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 296,99 | K |
| 84342 | VISIPAQUE 270MG I/ML | inj 10x50ml | NYI | N | |||
| 84343 | VISIPAQUE 270MG I/ML | inj 10x100ml | NYI | N | |||
| 84344 | VISIPAQUE 270MG I/ML | inj 6x200ml | NYI | N | |||
| 45121 | VISIPAQUE 270MG I/ML | inj 6x200ml | NRI | IRL | |||
| 45119 | VISIPAQUE 270MG I/ML | inj 10x50ml | NRI | IRL | |||
| 517.45 | V08AB09 | iodixanol (koncentrace 320mgI/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 376,27 | K |
| 84345 | VISIPAQUE 320MG I/ML | inj 10x20ml | NYI | N | |||
| 45122 | VISIPAQUE 320MG I/ML | inj 10x20ml | NRI | IRL | |||
| 517.46 | V08AB09 | iodixanol (koncentrace 320mgI/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 302,37 | K |
| 84346 | VISIPAQUE 320MG I/ML | inj 10x50ml | NYI | N | |||
| 84347 | VISIPAQUE 320MG I/ML | inj 10x100ml | NYI | N | |||
| 84348 | VISIPAQUE 320MG I/ML | inj 6x200ml | NYI | N | |||
| 45123 | VISIPAQUE 320MG I/ML | inj 10x50ml | NRI | IRL | |||
| 45125 | VISIPAQUE 320MG I/ML | inj 6x200ml | NRI | IRL | |||
| 45124 | VISIPAQUE 320MG I/ML | inj 10x100ml | NRI | IRL | |||
| 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | |||
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg I/ml) | parent. | 10 | ML | 74,25 | K |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg I/ml) | parent. | 10 | ML | 37,39 | K |
| 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 39,35 | K |
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | |||
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 462,54 | K |
| 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D | |||
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | |||
| 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 33,29 | K |
| 06303 | MICROPAQUE | sus 1x2000ml | GUE | D | |||
| 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I | |||
| 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 154,12 | K |
| 44367 | MICROPAQUE CT | sus 1x2000ml/ 100gm | GUE | D | |||
| 46675 | MICROPAQUE CT | sus 1x2000ml/100gm | DEF | F | |||
| 520.3 | V08BA01 | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 45,75 | K |
| 91066 | MICROPAQUE COLON | plv 1x800gm | GUE | D | |||
| 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K |
| 62535 | PRONTOBARIO ESOFAGO | sus 6x250ml (tuba) | BCC | I | |||
| 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,08 | K |
| 56578 | PRONTOBARIO HD | plv 24x340gm | BCC | I | |||
| 06304 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUE | D | |||
| 521 | V08CA | paramagnetické kontrastní látky | parent. | K | |||
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| 75660 | MAGNEVIST | inj 1x10ml | SAG | D | |||
| 75659 | MAGNEVIST | inj 1x5ml | SAG | D | |||
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| 96352 | MAGNEVIST | inj 1x20ml | SAG | D | |||
| 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| 55822 | OMNISCAN 0.5MMOL/ML | inj 10x5ml | NYI | N | |||
| 78815 | OMNISCAN 0.5MMOL/ML | inj 10x10ml | NYI | N | |||
| 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| 78816 | OMNISCAN 0.5MMOL/ML | inj 10x15ml | NYI | N | |||
| 78817 | OMNISCAN 0.5MMOL/ML | inj 10x20ml | NYI | N | |||
| 521.5 | V08DA02 | mikročástice galgaktózy | parent. | 1 | GM | 1142,99 | H“. |
Čl. II
Tato vyhláška nabývá účinnosti dnem 1. října 1999.
Ministr:
MUDr. David, CSc. v. r.
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)